Standout Papers

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome 2021 2026 2022 2024236
  1. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome (2021)
    Florence Wong, S. Chris Pappas et al. New England Journal of Medicine

Immediate Impact

4 by Nobel laureates 4 from Science/Nature 61 standout
Sub-graph 1 of 19

Citing Papers

Diagnosis and Management of Cirrhosis and Its Complications
2023 Standout
Acute Kidney Injury in Patients with Cirrhosis
2023 Standout
5 intermediate papers

Works of S. Chris Pappas being referenced

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
2021 Standout
Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome
2016
and 4 more

Author Peers

Author Last Decade Papers Cites
S. Chris Pappas 1784 1359 684 65 2.2k
Pratima Sharma 2242 1418 1592 102 3.0k
Juan A. del Olmo 2059 1662 835 49 2.8k
Bent Adel Hansen 1587 861 837 45 2.4k
Phillip Harrison 2006 1638 728 74 3.0k
Conrado Fernández‐Rodríguez 1491 1685 596 104 2.8k
Emilio Fábrega 1202 1224 743 94 2.1k
Peter Ferenci 1731 1518 189 82 2.5k
Alastair O’Brien 1096 1086 438 61 1.9k
Vivek A. Saraswat 1068 924 923 106 2.0k
Filippo Schepis 2024 1647 794 71 3.1k

All Works

Loading papers...

Rankless by CCL
2026